Ovarian Cancer Health Risk from Talcum Powder: Women Using Talcum Powder Products Should Be Aware of a Potential Increased Ovarian Cancer Health Risk by Talcum Powder Ovarian Cancer Lawyer

Ovarian Cancer Health Risk from Talcum Powder: Women Using Talcum Powder Including Johnson's Baby Powder and Shower-to-Shower Products Should Be Aware of a Potential Increased Ovarian Cancer Health Risk That May Be Caused By Use of Talcum Powder Products by Talcum Powder Ovarian Cancer Lawyer Jason Coomer

Two recent multi-million dollar verdicts against Johnson & Johnson have found that this manufacturer of talcum powder products has failed to adequately warn women regarding the potential danger of an ovarian cancer health risk for women using these products.  These verdicts have led to over a thousand lawsuits being filed against Johnson & Johnson by women with ovarian cancer and families of women who have died from ovarian cancer.  For more information on this topic, please go to the following web page: Ovarian Cancer Talcum Powder Lawsuit Information.

Early Detection of Ovarian Cancer Can Save Lives & Increase a Woman's Chance of Survival

Ovarian cancer is a hard to detect form of cancer that forms in a woman's ovary. It commonly results in abnormal cells that have the ability to metastasize to other parts of a woman's body.  When ovarian cancer begins, there may be no or only vague symptoms. Symptoms do become more noticeable as the cancer progresses. These symptoms may include bloating, pelvic pain, abdominal swelling, and loss of appetite, among others. Common areas to which the cancer may spread include the lining of the abdomen, lining of the bowel and bladder, lymph nodes, lungs, and liver.

If ovarian cancer is caught and treated in an early stage, it may be curable. Treatment usually includes some combination of surgery, radiation therapy, and chemotherapy. Outcomes depend on the extent of the disease and the subtype of the cancer present. The overall five-year survival rate in the United States is 45%.

International Drug Company Professionals Can Earn Large Rewards By Anonymously Exposing Bribery Schemes in Pharmerging Markets by International Drug Company Whistelblower Reward Lawyer

International Drug Company Professionals Can Earn Large Rewards By Anonymously Exposing Bribery Schemes in Pharmerging Markets by International Drug Company Whistelblower Reward Lawyer Jason S. Coomer

International whistleblowers can recover large amounts of money for exposing international medicine procurement kickbacks, medicine supply chain bribes, and other violations of the Foreign Corrupt Practices Act.  As such, pharmaceutical representatives, international drug executives, government officials, physicians, health care providers, community activists, and other persons, who are the original source of specialized knowledge of international drug company bribes, international pharmaceutical company illegal kickback schemes, public health medicine procurement bribery schemes, and other illicit payments for drug procurement, medical device procurement, medication, pharmaceutical, and medical equipment contracts.

For more information on this topic, please go to the following web pages:  International Medicine Procurement Bribe Whistleblower Rewards and International Government Procurement Bribe Bounty Actions.

U.S. Foreign Bribery Penalties Of Tens of Millions of Dollars for Drugmakers Need to Be Increased To Prevent Continued Foreign Corrupt Practices Act Violations

Global drugmakers are paying tens of millions of dollars to settle U.S. allegations that they bribed their way across emerging markets, but harsher penalties may be needed to deter the practice in untapped regions where billions are at stake.

Federal authorities have cast a wide net to weed out suspected gift-giving and kickbacks to foreign doctors and government officials to gain a foothold in burgeoning new markets in Asia, Eastern Europe and Latin America.
At least eight of the world's top 10 drugmakers, including Bristol-Myers Squibb Co, Pfizer Inc and Johnson &, have disclosed U.S. probes under the 1977 Foreign Corrupt Practices Act (FCPA).

Pfizer agreed to pay $60 million this year to settle FCPA charges and J&J reached a $70 million settlement last year. Pfizer is on track to record $10 billion in sales from emerging markets this year, while J&J said Brazil, Russia, India and China accounted for just under 10 percent of the $65 billion in sales it reported last year.

Analysis: U.S. foreign bribery penalties for drugmakers may lack bite | Reuters

Bank FOREX Fraud and Foreign Exchange Rate Fraud Can Be The Basis of Large Whistleblower Rewards by Bank FOREX Fraud Whistleblower Reward Lawyer

Bank FOREX Fraud and Foreign Exchange Rate Fraud Can Be The Basis of Large Whistleblower Rewards by Bank FOREX Fraud Whistleblower Reward Lawyer Jason Coomer

Bank FOREX Fraud and Foreign Exchange Rate Fraud in the $5 trillion-a-day FOREX market can be the basis of large bounty action rewards.  These rewards can be paid to financial professionals who anonymously and properly expose significant bank foreign exchange rate fraud.  For more information on this topic, please go to the following web page: Bank Foreign Exchange Rate Fraud Lawyer: Confidential Reviews of Bounty Actions.    

Several Major Banks Have Been Fined Billions of Dollars For Attempting to Manipulate Foreign Exchange Rates

Seven major banks have been fined over $10 billion for failing to stop traders from trying to manipulate foreign exchange rates, which are used daily by millions of people from trillion-dollar investment houses to tourists buying foreign currencies on vacation.  By confidentially and properly reporting similar bank foreign exchange rate schemes of this magnitude, a financial professional or investor can earn large financial rewards.  An example of a reward based on a $10 billion fine by the SEC or CFTC could be between $1 billion to $3 billion.  These rewards are designed to encourage financial professionals with original knowledge of significant investment fraud schemes to expose the fraud.  Included in these laws are confidentially protections that allow a financial professional to anonymously expose these schemes through a lawyer.